Autophagy based cellular physiological strategies target oncogenic progression

Prashant Kumar1, Yuvraj Anandrao Jagtap1, Som Mohanlal Patwa1

  • 1Department of Bioscience & Bioengineering, Cellular and Molecular Neurobiology Unit, Indian Institute of Technology Jodhpur, Jodhpur, Rajasthan, India.

Insights

Defective proteostasis, or protein balance, is linked to cancer. Autophagy, a cellular cleaning process, is crucial for preventing tumors, but its exact role in cancer suppression needs further research.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Cancer Research

Background:

  • Defective proteostasis (protein balance) is increasingly recognized as a risk factor for cancer development.
  • Misfolded protein accumulation disrupts cellular homeostasis, promoting abnormal cell proliferation and tumorigenesis.
  • Autophagy, a cellular degradation pathway, is vital for clearing damaged components and maintaining cellular balance, thus preventing cancer.

Purpose of the Study:

  • To elucidate the precise molecular mechanisms by which autophagy suppresses tumors.
  • To investigate how autophagy initiates selective or non-selective degradation to counteract tumor promotion under stress.
  • To explore the detailed molecular functions of autophagy in human cancers for therapeutic targeting.

Main Methods:

  • Review and synthesis of existing literature on autophagy and cancer.
  • Analysis of molecular pathways involved in autophagic flux and tumor suppression.
  • Examination of autophagy-based theragnostic strategies in various stages of tumorigenesis.

Main Results:

  • Functional autophagy is essential for maintaining cellular homeostasis and preventing tumorigenesis.
  • The exact molecular mechanisms of autophagy-mediated tumor suppression remain incompletely understood.
  • Autophagy plays a preventive role against tumor progression and can be targeted for cancer therapy.

Conclusions:

  • Understanding autophagy's role in tumor suppression is critical for developing novel cancer therapies.
  • Targeting autophagic flux offers promising theragnostic strategies for various phases of tumorigenesis.
  • Further research into autophagy's molecular partners will enhance therapeutic approaches against oncogenic transformation.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.1K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.9K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.6K